Filter
30
Filtered Results: 30
Text search:
G.
Behrens
Featured
New Publications
12
Language
Document type
Studies & Reports
10
Guidelines
10
No document type
8
Manuals
2
Countries / Regions
Germany
4
Western and Central Europe
2
Peru
1
Haiti
1
Asia
1
Latin America and the Carribbean
1
South Africa
1
Brazil
1
Authors & Publishers
Publication Years
Category
COVID-19
3
Guidelines
3
Studies & Reports
2
HIV & STI
2
Dental & Eye Care
1
Trachoma
1
Lymphaticfilariasis
1
Cervical Cancer
1
Chagas
1
Policies & Guidelines HIV & TB
1
Gynaecology & Obstetrics
1
Leprosy
1
NTDs & Others
1
Disease Prevention & Control
1
Toolboxes
Clinical Guidelines
6
Immunization Guidelines
4
Europe
2
Mental Health
2
General
2
Substance Use Disorders & Addiction
2
Behaviour Change/Life Skill Education
1
ART Drug Resistance
1
Intercultural Competence
1
Clinical Aspects
1
Violence & Protection
1
Germany
1
Treatment Guidelines HIV
1
Others
1
Child Health / Pediatrics
1
Mental Health Guidelines
1
Cannabis
1
Studies
1
Country specific documents
1
Long COVID/ Post-COVID Syndrome
1
Extreme Situations
1
Falsified & Substandard
1
Guidelines & Manuals
1
Chagas
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Overview, Studies & Reports
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
Miscellaneous
1
Health Care Systems
1
HIV and coinfection
1
Antiretroviral Treatment ART
1
HIV in Key Populations
1
Reports & Studies
1
Accessed: 08.11.2020
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Volume 2 · Supplement 4 · November 2016
ISSN 2055-66-40 – Print
Foreword
| ISSN 2055-66-59 – Online
www.viruseradication.com
Brussels, December 16. 2016
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
Wie passen Trauma und Empowerment zusammen? Was ist den Konzepten gemein und welche Entwicklungen machen sie durch? Wie können komplexe Machtverhältnisse auf individüller und struktureller Ebene beruecksichtigt und überwunden werden?
Diese Publikation der Bundesweiten Arbeitsgemeinschaft der Ps...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
AWMF Leitlinie, 12.7.2021
Orientations provisoires 19 juillet 2021
interim guidance, 19 July 2021 (arabic version)
Updated Treatment Guidelines
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and...
The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost t...
